This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of rivastigmine
ADMED_ACHEI_RIVASTIGMINE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
6520 |
4. Check minimum number of events
Min. number of events
3
|
6520 |
5. Include endpointsNone |
6520 |
6. Filter based on genotype QC (FinnGen only) |
6352 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Use of rivastigmine
based on the number of shared cases.
Similar with more cases:
- Use of anticholinesterases
- N06DA Anticholinesterases
- Unspecific neurodegenerative disorder
- Dementia
- Dementia, including avohilmo
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6352 | 3201 | 3151 |
| Unadjusted period prevalence (%) | 1.29 | 1.14 | 1.44 |
| Median age at first event (years) | 78.92 | 79.45 | 78.37 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 6520
- Matched controls
- 65010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
8.3
307.7
888
1206
N06DA02
ATC
donepezil; oral
6.2
307.7
1987
4288
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
13.4
307.7
332
259
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
17.1
307.7
2659
2523
G30.0
ICD-10 Finland
Alzheimer disease with early onset
13.4
307.7
388
305
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
6.5
307.7
814
1391
N06DA03
ATC
rivastigmine; oral, transdermal
+∞
307.7
6520
624
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
9.2
307.7
1510
2054
G30.1
ICD-10 Finland
Alzheimer disease with late onset
13.5
307.7
3208
4348
G30
ICD-10 Finland
Alzheimer disease
9.3
307.7
476
546
SPAT1053
SPAT
Memory test
3.3
307.7
2614
11001
G30.8
ICD-10 Finland
Other Alzheimer disease
7.4
307.7
937
1446
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
23.0
307.7
379
174
N05AX08
ATC
risperidone; systemic
5.7
307.7
1856
4223
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.4
307.7
1852
5335
G20
ICD-10 Finland
Parkinson disease
7.9
307.7
957
1388
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
7.7
307.7
484
669
P20
ICPC
Memory disturbance
6.0
307.7
3387
9926
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
9.2
307.7
1658
2318
N05AH04
ATC
quetiapine; oral
4.5
307.7
1879
5314
N06DX01
ATC
memantine; oral
13.3
307.7
3567
5421
N87
ICPC
Parkinsonism
11.0
307.7
492
479
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
7.6
307.7
1127
1735
P70
ICPC
Dementia
8.4
307.7
947
1292
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
17.6
290.9
239
140
N06DA04
ATC
galantamine; oral
4.8
274.4
659
1474
N04BD01
ATC
selegiline; oral
7.9
257.6
361
476
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
11.4
254.0
269
245
A28
ICPC
Limited function/disability NOS
2.4
229.0
2448
13125
F03
ICD-10 Finland
Unspecified dementia
3.3
228.1
974
3266
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.3
203.2
844
2772
N04BD02
ATC
rasagiline; oral
12.3
199.5
200
167
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.6
195.0
1336
5774
R41.3
ICD-10 Finland
Other amnesia
4.1
183.7
540
1403
F0019, G301,
ICD-10 Finland
7.4
178.1
264
370
F06.7
ICD-10 Finland
Mild cognitive disorder
3.8
176.9
575
1604
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
59.3
157.0
88
15
N04BC04
ATC
ropinirole; oral
8.1
157.0
214
272
N06AB10
ATC
escitalopram; oral
2.5
153.3
1159
5198
193
Kela drug reimbursment
Rasagiline
12.1
151.5
153
129
N06AX11
ATC
mirtazapine; oral
2.0
147.1
2486
15326
R53
ICD-10 Finland
Malaise and fatigue
2.0
144.8
2152
12661
SPAT1216
SPAT
Assessment of functional ability
2.1
144.0
1843
10260
N05BA04
ATC
oxazepam; oral
2.0
139.7
2093
12319
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
5.9
131.1
240
418
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
7.2
125.5
189
269
WYA20
NOMESCO Finland
Home visit
4.1
123.3
353
895
TAB00
NOMESCO Finland
Lumbar puncture
4.1
119.0
338
852
SPAT1234
SPAT
Support of social functional capacity
2.6
114.7
757
3157
F05.1
ICD-10 Finland
Delirium superimposed on dementia
6.0
114.3
206
353
XA800
NOMESCO Finland
Neuropsychological investigation
4.6
113.2
277
622
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
109.9
2802
19221
AA1AD
NOMESCO Finland
CT of head and brain
1.8
107.0
2486
16554
N06AX26
ATC
vortioxetine; oral
3.2
103.2
426
1377
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.6
98.2
641
2650
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
95.3
1651
9977
N05AH03
ATC
olanzapine; systemic
3.3
92.8
374
1190
N04BX02
ATC
entacapone; oral
9.5
90.1
107
114
R41.0
ICD-10 Finland
Disorientation, unspecified
2.8
85.9
469
1770
I95.1
ICD-10 Finland
Orthostatic hypotension
2.5
82.1
558
2345
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.1
82.0
897
4604
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
80.6
1959
12973
A04
ICPC
Weakness/tiredness general
1.9
79.4
1293
7604
N02BE01
ATC
paracetamol; systemic, rectal
2.0
78.0
5682
50069
N03AG01
ATC
valproic acid; systemic, rectal
2.8
76.0
405
1507
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
5.0
73.0
158
320
F009, G309,
ICD-10 Finland
5.9
70.9
129
223
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
69.9
1528
9760
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
68.0
512
2249
SPAT1254
SPAT
Administration of medicine
1.7
65.4
1399
8861
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
9.1
63.1
77
85
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
9.4
63.1
75
80
SPAT1301
SPAT
No procedures
1.6
62.3
2360
17217
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.9
61.1
820
4495
N04BC09
ATC
rotigotine; transdermal
8.2
58.7
78
96
N04BC05
ATC
pramipexole; oral
2.0
58.3
655
3371
N05BA06
ATC
lorazepam; systemic, sublingual
2.3
57.1
486
2246
G04BD12
ATC
mirabegron; oral
1.8
56.3
1036
6257
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.2
55.9
506
2398
U04
ICPC
Incontinence urine
2.1
55.8
590
2969
SPAT1304
SPAT
Counselling and guidance related to ageing
1.8
55.6
919
5376
A06AD11
ATC
lactulose; oral
1.6
54.5
1531
10341
N05AD01
ATC
haloperidol; systemic
2.6
54.0
326
1290
L28
ICPC
Limited function/disability (L)
1.6
53.9
1686
11680
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
116.7
53.8
58
5
A29
ICPC
General symptom/complaint other
1.8
53.1
1013
6172
S01.0
ICD-10 Finland
Open wound of scalp
2.0
53.1
677
3639
F0009, G300,
ICD-10 Finland
7.2
52.2
77
107
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.8
50.7
809
4671
ICB01, ,
SPAT
7.7
50.7
71
93
SPAT1101
SPAT
Orthostatic test
2.1
50.2
545
2766
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.9
49.9
651
3522
R1250
NOMESCO Finland
Evaluation of functional capability
3.4
48.4
176
524
F00
ICD-10 Finland
Dementia in Alzheimer disease
6.3
48.4
81
129
N02AA05
ATC
oxycodone; systemic
1.6
47.9
1599
11197
F0014, G301,
ICD-10 Finland
8.6
47.1
60
70
130
Kela drug reimbursment
Malignant tumour
0.3
46.9
137
4335
SPAT1229
SPAT
Assessment of need for aid
1.8
46.2
784
4605
H02AA02
ATC
fludrocortisone; oral
4.2
44.2
120
292
F0029, G308,
ICD-10 Finland
7.8
42.8
59
76
R55
ICD-10 Finland
Syncope and collapse
1.7
42.7
997
6387
AXX01, ,
SPAT
2.4
42.6
307
1318
SPAT1050
SPAT
Extensive neurological examination
2.9
42.4
210
750
N06AB04
ATC
citalopram; systemic
1.6
40.6
1279
8792
N04BX04
ATC
opicapone; oral
15.2
39.8
35
23
S06.0
ICD-10 Finland
Concussion
1.7
39.2
723
4339
S72.0
ICD-10 Finland
Fracture of neck of femur
1.9
38.3
527
2893
SPAT1252
SPAT
Overall medication plan or its review
1.8
38.3
629
3649
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
38.2
1294
9023
H02AB02
ATC
dexamethasone; systemic
0.4
37.6
155
4152
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.1
37.4
364
1769
R44.1
ICD-10 Finland
Visual hallucinations
4.5
36.4
89
200
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
36.3
975
6441
Z75.5
ICD-10 Finland
Holiday relief care
3.2
36.0
145
461
J01CA08
ATC
pivmecillinam; oral
1.4
35.9
2495
19923
R25.1
ICD-10 Finland
Tremor, unspecified
2.4
35.1
252
1080
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.8
34.8
180
658
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.0
34.8
390
1997
W19
ICD-10 Finland
Unspecified fall
1.7
34.8
738
4595
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
2.7
34.7
191
722
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
6.7
34.6
55
83
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
2.8
34.5
173
623
N30.0
ICD-10 Finland
Acute cystitis
1.5
34.4
1161
8071
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
65.1
33.9
39
6
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
33.6
1100
15310
R42
ICD-10 Finland
Dizziness and giddiness
1.4
33.2
1771
13457
Z29
ICPC
Social problem NOS
2.8
33.1
173
636
F21, ,
ICPC
3.1
32.8
136
440
AXX01
NOMESCO Finland
Memory assessment
8.0
32.7
44
55
N28
ICPC
Limited function/disability (N)
2.8
32.5
162
581
J01DB01
ATC
cefalexin; oral
1.4
32.3
4698
42028
F001, G301,
ICD-10 Finland
6.1
31.7
55
91
SPAT1360
SPAT
Extensive global examination
1.7
31.4
561
3329
N29
ICPC
Neurological sympt/complt other
2.8
31.3
161
588
A98
ICPC
Health maint/preventive medicine
1.5
31.2
5309
48659
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
3.2
30.4
121
382
J01EA01
ATC
trimethoprim; systemic
1.4
29.8
1870
14560
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
29.6
1153
8230
N06AB06
ATC
sertraline; oral
1.8
29.4
458
2610
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
7.1
28.7
43
61
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
28.6
478
2782
AA1CG, ,
SPAT
4.5
28.3
68
151
XF606
NOMESCO Finland
Ortostatic test
3.7
27.9
89
244
SPAT1139
SPAT
Nutrition survey
2.1
27.7
282
1393
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
3.3
27.6
102
308
F05.9
ICD-10 Finland
Delirium, unspecified
2.2
26.7
230
1066
S70.0
ICD-10 Finland
Contusion of hip
1.9
26.5
348
1880
SPAT1284
SPAT
Extensive health certificate
2.5
26.5
162
646
Z2445
NOMESCO Finland
Psychologist
2.9
26.2
124
433
WYA20, ,
SPAT
4.4
26.0
64
145
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
25.5
2141
17357
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
25.3
468
2799
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
6.0
25.3
44
73
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
24.9
1750
13797
G04CA02
ATC
tamsulosin; oral
1.4
24.9
1829
14521
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.6
24.7
707
4716
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
2.5
24.2
155
632
F0232, G20,
ICD-10 Finland
56.1
24.0
28
5
KMAK, ,
NOMESCO Finland
1.3
23.9
2148
17544
A03FA01
ATC
metoclopramide; systemic, rectal
0.7
23.9
672
9759
A27
ICPC
Fear of other disease NOS
1.8
23.7
339
1881
N07AA06, ,
ATC
240.1
23.6
24
*
N04BC06
ATC
cabergoline; oral
6.0
23.3
41
69
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.1
23.1
224
1087
F02.80
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without additional symptoms
36.3
22.9
29
8
N03AE01
ATC
clonazepam; systemic
1.8
22.9
333
1857
F0230, G20,
ICD-10 Finland
65.0
22.8
26
*
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
7.1
22.8
34
48
R5110, ,
SPAT
1.6
22.6
491
3064
C03DA01
ATC
spironolactone; oral
0.6
22.4
490
7533
N27
ICPC
Fear of neurological disease other
2.5
22.4
144
588
C10AA01
ATC
simvastatin; oral
1.3
22.2
3434
30080
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.6
21.6
385
6220
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
115.1
21.5
23
*
G04CB01
ATC
finasteride; oral
1.4
21.4
980
7172
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.0
21.4
230
1161
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
21.3
350
2025
SPAT1251
SPAT
Organisation of medication
1.8
20.4
321
1834
A04AA02
ATC
granisetron; systemic, transdermal
0.3
20.3
63
1949
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.7
20.0
915
12180
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
20.0
2837
24453
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
4.4
20.0
50
115
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.2
20.0
26
1344
P29
ICPC
Psychological sympt/compl other
2.1
19.9
179
845
N04BB01
ATC
amantadine; oral
2.7
19.8
104
385
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
19.5
1214
9341
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
6.6
19.5
31
47
IHZ08
NOMESCO Finland
Provision of support and information for patient’s relatives
7.4
19.4
28
38
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
19.0
2464
20958
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
18.6
3071
26872
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
18.2
1864
15368
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.1
18.2
181
889
OAB41
NOMESCO Finland
Guidance and counselling related to ageing
5.3
18.1
36
68
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.2
17.9
31
1332
S00.0
ICD-10 Finland
Superficial injury of scalp
2.0
17.7
184
919
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
5.6
17.6
33
59
N06AX16
ATC
venlafaxine; oral
1.6
17.6
466
3046
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.7
17.5
302
1773
OAB76
NOMESCO Finland
General guidance on nutrition and food
6.8
17.3
27
40
R06.0
ICD-10 Finland
Dyspnoea
0.8
17.3
1211
15149
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
17.0
1021
7795
R11
ICD-10 Finland
Nausea and vomiting
1.5
16.9
552
3775
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.6
16.9
426
2753
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
0.6
16.9
337
5309
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.3
16.7
34
1321
Z02.7
ICD-10 Finland
Issue of medical certificate
1.6
16.5
431
2808
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.5
16.5
106
434
A78
ICPC
Infectious disease other/NOS
2.8
16.5
80
285
P03
ICPC
Feeling depressed
1.8
16.4
246
1386
M04AA01
ATC
allopurinol; systemic
0.7
16.4
612
8471
B03BA03
ATC
hydroxocobalamin; parenteral
1.5
16.4
497
3349
R63.4
ICD-10 Finland
Abnormal weight loss
1.8
16.3
264
1522
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
3.2
16.3
64
202
W0A10
NOMESCO Finland
Mapping of psychosocial situation
5.8
16.1
29
50
F06.0
ICD-10 Finland
Organic hallucinosis
4.9
16.0
35
72
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
4.4
16.0
40
92
N99
ICPC
Neurological disease other
2.6
15.9
88
336
D12
ICPC
Constipation
1.7
15.7
271
1590
E0000UV, ,
ATC
1.3
15.6
2201
18788
R35
ICD-10 Finland
Polyuria
1.5
15.5
443
2947
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
15.5
917
6978
SPAT1244
SPAT
Occupational therapy
2.7
15.2
82
309
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
2.4
15.1
106
452
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.3
15.1
116
515
XQ855, ,
SPAT
3.0
15.0
67
228
K59.0
ICD-10 Finland
Constipation
1.5
14.9
416
2752
G04BD08
ATC
solifenacin; oral
1.5
14.9
504
3473
F0011, G301,
ICD-10 Finland
5.7
14.8
27
47
WX212
NOMESCO Finland
Femoral plexus blockade
1.9
14.8
189
1014
SPAT1307
SPAT
Psychosocial counselling and guidance
2.1
14.6
145
713
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
14.5
2652
23241
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
14.4
1735
14518
R1250, ,
SPAT
2.3
14.3
111
496
N17
ICPC
Vertigo/dizziness
1.4
14.2
838
6369
N05AX12
ATC
aripiprazole; systemic
2.9
14.1
65
225
XF600, ,
SPAT
1.9
14.1
173
916
SCA01
NOMESCO Finland
Preventive oral health care, short
1.3
14.1
999
7802
S01.8
ICD-10 Finland
Open wound of other parts of head
2.3
14.0
101
437
JN4AD
NOMESCO Finland
Body CT examination
0.6
14.0
278
4390
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.7
14.0
245
1446
WZC30
NOMESCO Finland
Teaching
0.7
13.9
400
5833
J01MA02
ATC
ciprofloxacin; systemic
1.2
13.9
2459
21443
G04CB02
ATC
dutasteride; oral
1.4
13.8
561
4001
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
13.8
571
4088
D07AA02
ATC
hydrocortisone; topical
1.4
13.7
652
4781
LAITO, ,
NOMESCO Finland
4.8
13.7
30
62
K02.1
ICD-10 Finland
Caries of dentine
1.2
13.7
2273
19682
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
13.5
13.7
23
17
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.4
13.7
621
4520
N02AJ06
ATC
codeine and paracetamol; systemic
0.8
13.6
1329
16020
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
3.4
13.6
47
137
F01.2
ICD-10 Finland
Subcortical vascular dementia
2.7
13.6
70
258
I50.1
ICD-10 Finland
Left ventricular failure
0.6
13.5
178
3125
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
5.9
13.5
24
41
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.7
13.4
274
1683
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.8
13.4
206
1170
R03BB04
ATC
tiotropium bromide; inhalant
0.7
13.4
380
5559
S72.1
ICD-10 Finland
Pertrochanteric fracture
1.7
13.4
243
1447
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.3
13.4
45
1332
R33
ICD-10 Finland
Retention of urine
1.4
13.4
633
4638
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
13.2
1592
13293
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
0.4
13.1
84
1872
SPAT1231
SPAT
Assessment of adjustments needed in living environment
1.8
13.1
182
1004
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.6
13.1
287
1796
XKD00
NOMESCO Finland
Uroflowmetry
1.3
13.1
1091
8706
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.6
13.0
331
2147
N06AX21
ATC
duloxetine; oral
1.5
12.9
484
3402
N05AH02
ATC
clozapine; systemic
3.9
12.9
37
95
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
12.9
12
778
SPAT1285
SPAT
Provision of consultation response
1.6
12.8
317
2042
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
12.7
229
1362
SPAT1167
SPAT
Insertion of urinary catheter
1.6
12.5
294
1870
N04BC02
ATC
pergolide; oral
5.9
12.5
22
37
XQ858, ,
SPAT
3.7
12.4
38
102
N04AA02
ATC
biperiden; systemic
2.4
12.4
79
324
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
1.9
12.3
156
837
F00.22
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations
9.6
12.2
24
25
F05.8
ICD-10 Finland
Other delirium
2.5
12.1
71
280
A01
ICPC
Pain general/multiple sites
1.4
12.0
542
3940
S09.9
ICD-10 Finland
Unspecified injury of head
2.1
12.0
104
487
SPAT1263
SPAT
Sampling
1.2
11.9
2383
20940
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
2.6
11.9
69
271
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
1.9
11.8
150
804
UGC12
NOMESCO Finland
Flexible bronchoscopy
0.6
11.7
244
3816
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.7
11.7
189
1091
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.4
11.7
547
4001
I50.9
ICD-10 Finland
Heart failure, unspecified
0.8
11.5
1067
12986
R44.3
ICD-10 Finland
Hallucinations, unspecified
3.0
11.5
49
163
S01.3
ICD-10 Finland
Open wound of ear
2.5
11.5
73
299
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
11.1
11.5
21
19
ZXY02
NOMESCO Finland
Neuropsychologist
5.0
11.4
24
48
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.2
11.4
9
513
XX3DW
NOMESCO Finland
Time consuming IT work
0.6
11.4
276
4170
SPAT1014
SPAT
Treatment of eyes
1.9
11.3
149
809
U13
ICPC
Bladder symptom/complaint other
1.7
11.2
193
1136
SPAT1276
SPAT
Outlining of treatment with patient or their family members
1.8
11.1
169
960
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
1.8
11.0
173
992
L01BC06
ATC
capecitabine; oral
0.4
11.0
48
1250
SPAT1325
SPAT
Vaccination
1.2
11.0
2286
20127
T08
ICPC
Weight loss
2.1
11.0
106
518
F0013, G301,
ICD-10 Finland
13.8
10.9
18
13
EBA00
NOMESCO Finland
Extraction of tooth
1.2
10.9
1541
13059
SCA02
NOMESCO Finland
Preventive oral health care
1.5
10.7
349
2386
H25.8
ICD-10 Finland
Other senile cataract
0.8
10.7
662
8503
J96.1
ICD-10 Finland
Chronic respiratory failure
0.3
10.7
38
1092
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
0.3
10.7
24
878
F002, G308,
ICD-10 Finland
5.1
10.7
22
43
G31.0
ICD-10 Finland
Circumscribed brain atrophy
2.9
10.7
49
170
A04AA01
ATC
ondansetron; systemic, rectal
0.6
10.7
162
2735
TQW40, ,
SPAT
0.5
10.6
109
2061
L89
ICD-10 Finland
Decubitus ulcer and pressure area
1.8
10.6
156
878
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
2.5
10.6
63
251
N30.9
ICD-10 Finland
Cystitis, unspecified
1.4
10.6
424
3019
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.7
10.5
32
86
SPAT1260
SPAT
Consultation of another employee
1.3
10.5
1005
8146
J01CA04
ATC
amoxicillin; systemic
1.2
10.4
4207
39224
SPAT1104
SPAT
Monitoring of emergency patient
1.4
10.3
398
2813
F0022, G308,
ICD-10 Finland
16.0
10.3
16
10
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.6
10.3
232
3560
G23.8
ICD-10 Finland
Other specified degenerative diseases of basal ganglia
8.1
10.3
22
27
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
8.1
10.3
22
27
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.3
10.3
658
5054
R03AK03
ATC
[U] fenoterol and ipratropium bromide
0.6
10.2
218
3390
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.1
10.2
5
392
R51.80
ICD-10 Finland
Headache
1.4
10.2
581
4387
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
10.2
1831
15874
Z20.8
ICD-10 Finland
Contact with and exposure to other communicable diseases
1.8
10.1
136
745
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
5.3
10.1
20
38
AA1AD, ,
SPAT
3.9
10.1
29
75
F32
ICD-10 Finland
Depressive episode
1.8
10.0
156
893
R2110
NOMESCO Finland
Giving the first information
1.5
10.0
274
1808
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
8.4
10.0
21
25
F02.3
ICD-10 Finland
Dementia in Parkinson disease
39.9
9.9
12
*
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
9.9
881
7069
WW500
NOMESCO Finland
Blood transfusion
0.5
9.9
75
1564
-1, ,
ICPC
1.6
9.8
198
1215
P05
ICPC
Senility, feeling/behaving old
2.4
9.8
62
254
W06
ICD-10 Finland
Fall involving bed
2.2
9.8
81
373
T90.5
ICD-10 Finland
Sequelae of intracranial injury
2.7
9.8
51
190
359
Kela drug reimbursment
Mirabegroni
2.6
9.8
56
219
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
20.0
9.8
14
7
F02.82
ICD-10 Finland
Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations
20.0
9.8
14
7
H02AB06
ATC
prednisolone; systemic
0.8
9.7
2204
24579
D17
ICPC
Incontinence of bowel
2.2
9.7
76
343
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
0.6
9.6
151
2526
F00.21
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism
5.3
9.6
19
36
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.7
9.6
483
6393
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1.5
9.5
265
1756
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.7
9.5
305
4356
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.5
9.4
299
2035
Z01.8
ICD-10 Finland
Other specified special examinations
1.2
9.4
1118
9277
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
+∞
9.4
9
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.7
9.3
170
1018
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
0.2
9.3
9
448
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
6.9
9.3
22
32
T03
ICPC
Loss of appetite
3.1
9.3
37
119
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.0
9.2
92
456
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.0
9.2
38
125
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
0.5
9.2
64
1375
E86
ICD-10 Finland
Volume depletion
1.6
9.1
206
1303
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.6
9.0
182
2865
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.4
9.0
37
989
P99
ICPC
Psychological disorders other
2.3
9.0
64
277
F00.04
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type
15.5
9.0
14
9
F02.8
ICD-10 Finland
Dementia in other specified diseases classified elsewhere
36.6
9.0
11
*
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
2.1
8.8
81
390
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.2
8.8
7
395
G04BD10
ATC
darifenacin; oral
2.3
8.8
63
274
-, ,
ICD-10 Finland
1.7
8.7
142
825
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.1
8.7
80
385
S01
ICD-10 Finland
Open wound of head
2.1
8.7
80
385
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.5
8.7
83
1601
N02AX02
ATC
tramadol; systemic, rectal
0.8
8.7
1951
21845
AA1DD
NOMESCO Finland
Head and neck CT
3.5
8.6
28
79
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
8.6
1462
12578
U28
ICPC
Limited function/disability (U)
2.0
8.5
87
435
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
2.7
8.5
42
153
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.3
8.5
656
5170
F0004, G300,
ICD-10 Finland
27.5
8.5
11
*
Z00.6
ICD-10 Finland
Examination for normal comparison and control in clinical research programme
3.1
8.5
34
110
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.5
8.4
218
1422
G04CA01
ATC
alfuzosin; oral
1.3
8.4
741
5934
-1, ,
NOMESCO Finland
1.2
8.4
1205
10191
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
0.6
8.4
120
2054
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
0.6
8.4
160
2548
SPAT1279
SPAT
Preparation of immediate hospitalisation
1.8
8.4
112
614
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
1.9
8.4
94
487
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
3.6
8.3
27
76
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
0.2
8.2
8
397
WZC00
NOMESCO Finland
Treatment plan or consultation
0.8
8.2
1232
14309
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
8.2
831
6772
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.3
8.1
607
4759
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
0.2
8.1
9
411
SPAT1310
SPAT
Counselling related to known health issue
1.2
8.1
1656
14468
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
0.1
8.1
*
288
F02.84
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere as other mixed symptoms of mixed type
33.3
8.1
10
*
SPAT1240
SPAT
Therapeutic discussion
1.5
8.1
270
1861
K59.09
ICD-10 Finland
Constipation, unspecified
1.4
8.0
441
3310
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
0.3
8.0
18
652
N80
ICPC
Head injury other
1.9
8.0
101
544
A10BK01
ATC
dapagliflozin; oral
0.6
8.0
145
2337
F0024, G301,
ICD-10 Finland
22.0
8.0
11
5
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
8.0
561
4365
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
8.0
1662
14545
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
2.9
7.9
36
125
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
0.5
7.9
80
1513
F00, F03,
ICD-10 Finland
4.3
7.9
20
47
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
0.2
7.9
5
326
-2, ,
ICPC
2.3
7.9
58
256
XF606, ,
SPAT
2.5
7.8
46
183
G04BD11
ATC
fesoterodine; oral
1.5
7.8
201
1311
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
0.2
7.8
12
545
L03AA13
ATC
pegfilgrastim; parenteral
0.4
7.8
48
1078
A04AA55
ATC
palonosetron, combinations; systemic
0.2
7.7
10
506
G21.8
ICD-10 Finland
Other secondary parkinsonism
4.2
7.7
20
48
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
4.2
7.7
20
48
Z28
ICPC
Limited function/disability (Z)
2.5
7.7
47
191
AA1BG, ,
SPAT
2.2
7.6
59
266
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
2.0
7.6
83
427
D01BA02
ATC
terbinafine; oral
1.2
7.6
1223
10455
ZX120
NOMESCO Finland
Intravenous
0.7
7.5
273
3815
K59.1
ICD-10 Finland
Functional diarrhoea
1.4
7.5
291
2061
WF004
NOMESCO Finland
Palliative radiotherapy
0.4
7.5
30
808
I71.3
ICD-10 Finland
Abdominal aortic aneurysm, ruptured
0.2
7.5
8
373
R18
ICD-10 Finland
Ascites
0.3
7.5
22
687
F023, G20,
ICD-10 Finland
80.0
7.4
8
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
0.1
7.4
*
242
H50.52
ICD-10 Finland
Exophoria
2.6
7.4
40
153
F00.23
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression
8.3
7.3
15
18
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
0.4
7.3
31
810
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.5
7.3
247
1708
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
0.2
7.3
5
306
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.2
7.2
760
6213
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.8
7.2
688
8382
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
7.3
7.2
16
22
D07AC01
ATC
betamethasone; topical
1.2
7.1
1818
16148
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
0.2
7.1
7
344
G04BD07
ATC
tolterodine; oral
1.4
7.1
379
2834
SPAT1111
SPAT
Planning of analgesia
1.9
7.1
78
402
SPAT1172
SPAT
Guidance concerning hydration
1.5
7.1
222
1511
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
1.8
7.1
104
588
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.3
7.1
517
4045
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
0.8
7.0
511
6438
VALMI, ,
NOMESCO Finland
1.2
7.0
847
7028
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
2.6
7.0
37
140
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
2.6
7.0
38
146
A05
ICPC
Feeling ill
1.5
7.0
211
1427
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
0.6
7.0
143
2236
SFA10
NOMESCO Finland
One-surface restoration
1.2
6.9
2142
19300
A10AB05
ATC
insulin aspart; parenteral
1.3
6.9
414
3149
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
0.5
6.9
57
1150
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.3
6.9
524
4118
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.5
6.9
179
1171
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.6
6.9
166
1068
N30
ICD-10 Finland
Cystitis
1.3
6.9
382
2874
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.8
6.9
895
10560
I50.0
ICD-10 Finland
Congestive heart failure
0.8
6.8
509
6393
S80.0
ICD-10 Finland
Contusion of knee
1.4
6.8
269
1915
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
2.4
6.8
45
190
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.3
6.8
610
4898
WF003
NOMESCO Finland
Adjuvant radiotherapy
0.5
6.8
50
1047
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
0.4
6.8
31
783
N06AX12
ATC
bupropion; oral
1.8
6.8
99
560
L03AA14
ATC
lipegfilgrastim; parenteral
0.2
6.8
8
350
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
0.7
6.7
176
2614
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.7
1817
16198
F0282, G318,
ICD-10 Finland
39.9
6.7
8
*
F01.34
ICD-10 Finland
Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type
6.1
6.7
17
28
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
0.5
6.7
44
960
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
0.4
6.7
38
877
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
22.5
6.7
9
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.3
6.6
15
538
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.2
6.6
55
256
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
5.5
6.6
18
33
I42.0
ICD-10 Finland
Dilated cardiomyopathy
0.5
6.6
46
981
T05
ICPC
Feeding problem of adult
2.5
6.5
38
151
G04BD09
ATC
trospium; oral
1.5
6.5
175
1156
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
0.1
6.5
*
243
R32
ICD-10 Finland
Unspecified urinary incontinence
1.5
6.5
187
1253
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.2
6.5
903
7602
A02BC05
ATC
esomeprazole; systemic
1.2
6.5
2085
18823
K08.3
ICD-10 Finland
Retained dental root
1.3
6.5
366
2763
L01CA04
ATC
vinorelbine; systemic
0.1
6.5
*
266
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
1.7
6.4
103
598
N06BA04
ATC
methylphenidate; oral
6.1
6.4
16
26
HA1RA, ,
SPAT
0.4
6.4
29
735
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.2
6.4
725
5976
R03DA04
ATC
theophylline; systemic, rectal
0.7
6.4
225
3156
R03BB01
ATC
ipratropium bromide; inhalant
0.7
6.4
158
2370
JN4BD
NOMESCO Finland
Extensive body CT
0.8
6.4
382
4935
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
0.3
6.3
16
539
R31
ICD-10 Finland
Unspecified haematuria
1.2
6.3
675
5526
R54
ICD-10 Finland
Senility
2.1
6.3
57
274
Z08
ICPC
Social welfare problem
2.1
6.3
55
261
115
Kela drug reimbursment
Breast cancer
0.7
6.3
218
3069
Z00.0
ICD-10 Finland
General medical examination
1.2
6.3
981
8346
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
0.0
6.3
*
159
WF002
NOMESCO Finland
Radical radiotherapy
0.6
6.3
127
1990
A11CC03
ATC
alfacalcidol; systemic
0.4
6.3
36
827
AA052, ,
NOMESCO Finland
11.0
6.3
11
10
F01.24
ICD-10 Finland
Subcortical vascular dementia other additional symptoms of mixed type
3.6
6.3
20
56
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
0.4
6.3
30
742
M01AC06
ATC
meloxicam; systemic, rectal
1.2
6.3
1788
15993
P76
ICPC
Depressive disorder
1.6
6.3
131
817
F009, G300,
ICD-10 Finland
+∞
6.2
6
*
I95.9
ICD-10 Finland
Hypotension, unspecified
1.7
6.2
110
657
A99
ICPC
Disease/condition unspecnature/site
1.3
6.2
495
3916
U05
ICPC
Urination problems other
1.4
6.2
315
2339
F0001, G300,
ICD-10 Finland
26.6
6.2
8
*
U07
ICPC
Urine symptom/complaint other
1.3
6.2
419
3244
F0024, G308,
ICD-10 Finland
6.2
6.1
15
24
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.6
6.1
148
955
D10
ICPC
Vomiting
1.6
6.1
125
775
P01
ICPC
Feeling anxious/nervous/tense
1.5
6.1
193
1318
A02BC03
ATC
lansoprazole; oral
1.2
6.1
1659
14780
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
0.6
6.1
103
1683
S52.5
ICD-10 Finland
Fracture of lower end of radius
1.3
6.1
549
4411
WX402
NOMESCO Finland
General anaesthesia
0.8
6.1
504
6247
AA1AA
NOMESCO Finland
Head X-ray examination
2.1
6.1
53
252
N19
ICPC
Speech disorder
1.8
6.1
79
432
B01AB10
ATC
tinzaparin; parenteral
0.7
6.1
272
3666
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
321
287
11.68
307.21
1.0
1.0
49.48
45.06
ng/l
0.71
236
165
321
288
11.64
306.50
1.0
1.0
571.20
651.51
ng/l
2.21
231
161
316
286
11.53
299.94
1.0
1.0
373.18
337.85
ng/l
0.91
234
165
2568
14855
2.19
192.35
1.9
1.8
1227.67
1166.09
nmol/l
2.69
2003
10814
2637
15660
2.14
182.20
1.7
1.6
21.25
20.03
nmol/l
3.26
2292
13054
2108
12220
2.06
148.47
2.8
3.1
2.45
2.47
mmol/l
14.48
1862
10447
363
859
4.40
139.11
1.2
1.3
472.20
634.53
mg/l
3.33
335
807
331
749
4.59
134.19
1.1
1.2
3.74
3.93
mmol/l
2.56
303
689
324
729
4.61
132.27
1.2
1.4
347.98
869.21
e6/l
1.27
252
609
322
729
4.58
130.43
1.2
1.3
18.97
23.61
e6/l
0.13
237
581
3601
25810
1.87
129.50
2.4
2.2
91.48
92.55
pmol/l
0.69
1922
13049
2885
19970
1.79
109.65
2.5
3.2
2.35
2.35
mmol/l
0.04
2505
16729
4483
36650
1.70
82.00
6.3
5.7
1722.41
2343.60
e6/l
0.35
74
656
3335
25781
1.59
71.68
3.6
4.4
35.03
33.99
g/l
23.79
2992
23424
1948
13655
1.60
60.60
1.8
1.8
452.80
16060481.82
pmol/l
5.16
1591
10660
1202
7722
1.68
51.82
1.9
1.8
—
—
—
0
0
3665
30195
1.48
50.41
4.8
6.4
1.22
1.21
mmol/l
16.54
3070
25104
1200
7767
1.66
50.08
1.9
1.8
—
—
—
0
0
3349
27233
1.47
48.38
4.2
5.7
1.22
1.21
mmol/l
6.59
2995
24288
2723
21473
1.45
45.01
2.1
2.2
78.41
80.50
nmol/l
3.52
2350
18165
2511
19759
1.43
40.70
2.5
2.2
—
—
—
0
0
4085
35191
1.42
38.89
3.9
4.0
15.33
15.28
pmol/l
0.60
3599
30640
1585
11509
1.49
38.68
5.9
5.1
1.02
1.02
kg/l
1.37
215
1962
1539
11230
1.48
36.27
1.9
1.9
—
—
—
0
0
162
560
2.93
34.78
3.0
3.6
326.13
328.49
umol/l
0.07
130
450
5184
47073
1.48
34.07
18.2
19.5
30.52
28.15
mg/l
4.43
4382
39583
4777
42922
1.41
31.49
5.1
5.0
1.99
2.14
mu/l
3.86
4287
37676
3026
25291
1.36
31.43
5.0
4.6
0.00
0.00
estimate
0.01
589
5163
1810
13983
1.40
30.32
5.6
5.0
0.00
0.00
estimate
0.88
493
4374
2371
19151
1.37
30.27
5.5
5.1
—
—
—
0
0
2239
18021
1.36
28.86
2.2
2.1
243.07
216.86
u/l
0.69
2058
16654
2983
25166
1.34
27.81
6.3
6.1
0.00
0.00
estimate
-0.00
517
4617
5350
49457
1.44
26.75
22.4
23.7
139.78
139.39
mmol/l
18.43
5150
47915
3009
25527
1.33
26.50
4.9
4.6
0.00
0.00
estimate
0.80
521
4589
5352
49500
1.44
26.49
22.4
23.9
3.99
4.01
mmol/l
9.44
5144
47881
5375
49874
1.42
25.01
26.5
28.6
6.96
7.10
e9/l
3.22
5134
47791
5371
49868
1.42
24.56
26.6
28.6
4.26
4.29
e12/l
3.34
5129
47779
5370
49862
1.42
24.50
26.5
28.6
236.18
237.79
e9/l
1.01
5154
48008
5371
49877
1.42
24.46
26.7
28.8
128.61
129.43
g/l
3.80
5194
48653
5369
49858
1.42
24.42
26.6
28.7
38.06
38.32
%
1.65
4706
45193
612
4020
1.57
22.78
1.6
1.5
—
—
—
0
0
90
300
3.02
20.75
1.1
1.1
—
52.50
—
0
6
103
381
2.72
19.65
1.3
1.3
—
—
—
0
0
91
318
2.88
19.32
1.1
1.1
—
2.31
—
0
7
622
4358
1.47
16.92
1.8
1.7
—
—
—
0
0
2005
16840
1.27
16.56
2.3
2.4
3.00
3.22
mg/l
3.07
1655
14067
963
7326
1.36
16.35
10.0
9.5
—
—
—
0
0
72
251
2.88
15.44
1.1
1.1
—
—
—
0
0
1269
10157
1.31
15.08
2.9
3.0
1.41
1.63
e6/l
0.30
733
5944
2356
20328
1.24
15.03
3.9
4.1
148.69
138.64
e6/l
0.14
1646
14969
4305
39753
1.23
13.89
5.2
7.4
79.36
83.05
u/l
3.45
3932
36829
2722
24023
1.22
13.58
4.3
4.6
49.19
101.54
ng/l
1.82
2148
19324
1938
16543
1.24
13.22
3.3
3.5
0.45
0.56
e6/l
1.84
1502
12923
500
6881
0.70
12.73
2.8
3.7
7.51
25.12
ug/l
5.32
396
5727
575
7647
0.73
11.85
2.8
3.5
245.59
249.98
u/l
0.26
511
7070
64
243
2.64
11.77
2.0
1.4
15.45
14.85
umol/l
0.22
59
225
449
6196
0.70
11.56
1.2
1.2
13.88
15.48
u/ml
0.20
137
1981
1528
17842
0.81
11.38
3.2
3.7
7.03
10.23
mg/mmol
2.66
929
11044
145
2562
0.55
11.26
1.5
1.8
1.55
1.46
g/l
0.10
120
2236
68
280
2.44
10.62
1.2
1.2
2.23
2.19
mmol/l
0.08
63
257
3939
36488
1.19
10.52
3.9
4.3
13.86
16.35
mm/h
19.65
3527
32825
1460
12356
1.23
10.35
4.2
4.4
159.30
408.35
ng/l
2.80
1321
11066
3555
32697
1.18
10.09
4.1
4.7
6.84
6.95
mmol/l
2.19
3329
30732
1158
13770
0.80
9.99
2.3
2.9
6502.07
7489.39
umol/l
0.28
935
11373
4086
38071
1.19
9.85
21.4
22.9
15.21
15.64
%
4.81
3965
37188
1449
16767
0.82
9.49
2.8
3.1
433.21
366.27
mg/l
0.21
918
10586
53
205
2.59
9.47
1.3
1.3
—
—
—
0
0
1457
16820
0.82
9.27
2.7
3.1
6.72
6.62
mmol/l
0.42
1189
13507
517
6702
0.75
8.87
4.5
4.8
34.96
34.25
%
0.75
333
4183
35
112
3.13
8.85
1.7
1.2
83.65
131.52
nmol/l
1.07
26
77
52
1171
0.44
8.47
1.4
1.5
28.65
30.43
g/l
0.54
43
1026
2039
18108
1.18
8.27
3.5
3.6
161.76
114.15
e6/l
0.33
1549
14133
129
2152
0.59
8.17
2.6
4.0
57.37
96.69
u/ml
1.49
123
2035
72
1413
0.50
7.99
1.6
1.5
—
—
—
0
0
217
3198
0.67
7.96
2.4
2.7
10.57
10.76
g/l
0.25
187
2849
5071
48483
1.19
7.82
9.4
11.4
21.11
23.22
u/l
4.81
4737
45872
519
6587
0.77
7.59
1.2
1.3
45.35
41.59
iu/ml
0.20
177
2007
1127
9556
1.21
7.59
3.1
3.2
2.81
2.77
e6/l
0.05
614
5402
48
199
2.42
7.50
1.0
1.1
134.27
137.20
nmol/l
0.14
48
199
30
98
3.06
7.37
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
50
214
2.34
7.30
1.1
1.1
—
—
—
0
0
318
2302
1.40
7.28
1.2
1.3
—
—
—
0
0
105
1784
0.58
7.18
1.7
1.5
92.73
285.22
titre
2.29
11
89
32
112
2.86
7.00
1.1
1.1
—
—
—
0
0
31
107
2.90
6.95
1.1
1.1
—
—
—
0
0
52
1084
0.47
6.95
3.4
3.7
1.46
1.55
%
0.08
39
916
210
1422
1.49
6.90
1.2
1.2
—
—
—
0
0
48
211
2.28
6.62
1.1
1.1
—
—
—
0
0
32
116
2.76
6.58
1.1
1.1
—
—
—
0
0
31
111
2.79
6.52
1.1
1.1
—
—
—
0
0
210
1440
1.47
6.50
1.2
1.2
—
—
—
0
0
44
947
0.46
6.45
1.3
1.4
23363.93
68708.74
e6/l
2.81
29
574
31
766
0.40
6.45
1.2
1.4
7.02
6.51
mmol/l
0.37
26
706
296
3968
0.73
6.37
2.9
3.5
0.49
0.70
%
1.07
72
1410
32
119
2.69
6.29
1.1
1.1
—
—
—
0
0
119
1859
0.63
5.84
1.2
1.2
258.42
254.48
u/ml
0.02
98
1674
53
1028
0.51
5.79
1.3
1.5
1364.84
1859.11
e6/l
0.79
37
757
2193
23812
0.88
5.75
2.3
2.8
—
—
—
0
0
64
1168
0.54
5.74
1.2
1.2
—
—
—
0
0
320
4160
0.75
5.61
2.3
3.7
5.11
5.17
kpa
0.69
283
3865
154
2252
0.67
5.52
2.6
2.7
—
—
—
0
0
23
601
0.38
5.51
1.2
1.3
32.39
12.71
u/l
0.50
18
548
524
4245
1.25
5.43
4.7
6.0
24.64
24.57
mmol/l
0.19
490
4031
225
1620
1.40
5.41
1.2
1.2
—
—
—
0
0
680
8043
0.82
5.27
3.0
4.8
1.00
1.04
mmol/l
4.53
589
7241
1978
18014
1.14
5.15
4.9
5.7
6.03
4.85
ug/l
0.17
1691
15682
603
4998
1.22
5.06
1.5
1.6
—
—
—
0
0
17
50
3.40
4.99
1.1
1.1
—
—
—
0
0
2077
22481
0.88
4.97
4.5
5.5
0.63
0.62
%
0.21
1842
20506
69
1180
0.58
4.96
2.3
2.5
4.13
4.12
mmol/l
0.05
69
1171
69
1180
0.58
4.96
2.3
2.5
106.97
105.35
mmol/l
2.14
69
1171
468
5714
0.80
4.95
3.2
5.7
10.70
12.09
mmol/l
3.81
430
5305
224
1639
1.38
4.92
1.3
1.3
—
—
—
0
0
224
1639
1.38
4.92
1.3
1.3
—
—
—
0
0
2139
23100
0.89
4.92
4.5
5.5
2.86
2.78
%
0.75
1908
21077
335
2605
1.30
4.87
1.5
1.5
1.55
1.64
%
1.32
280
2077
38
174
2.18
4.85
3.7
2.8
27.10
29.50
umol/l
0.65
30
123
39
786
0.49
4.85
1.1
1.1
—
—
—
0
0
310
3965
0.77
4.84
2.3
3.7
1.80
2.09
mmol/l
0.72
201
2899
2153
23223
0.89
4.83
4.9
5.9
8.81
8.99
%
1.60
1921
21203
76
1255
0.60
4.78
2.0
2.7
22.20
806.67
u/ml
2.69
68
1139
11
384
0.28
4.76
2.3
1.4
—
—
—
0
0
758
6461
1.19
4.75
2.4
2.5
5.49
5.93
ug/l
0.34
575
5302
177
2450
0.71
4.73
2.4
3.0
50.57
58.91
mg/l
0.24
142
1995
178
2456
0.71
4.67
2.3
3.0
49.19
82.49
mg/l
0.77
143
2000
50
918
0.54
4.66
1.6
1.8
—
—
—
0
0
2149
23137
0.89
4.61
4.7
5.5
59.51
59.70
%
0.29
1921
21152
2194
23588
0.89
4.59
4.9
5.7
25.00
24.83
%
0.29
1959
21575
1443
12958
1.14
4.59
2.7
2.8
5.73
5.26
e6/l
0.58
1285
11551
39
187
2.09
4.47
1.0
1.1
32.67
44.41
mg/l
1.58
30
153
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
194
2610
0.73
4.36
2.0
2.6
0.39
0.35
u/ml
0.60
107
1517
37
176
2.10
4.33
1.0
1.1
243.45
301.38
mg/l
1.46
29
149
303
2369
1.29
4.27
3.0
3.5
1.28
1.45
mmol/l
2.60
298
2326
1856
17011
1.12
4.20
2.2
2.5
57.08
65.26
u/l
1.00
1672
15499
1583
14377
1.13
4.17
4.6
5.0
21.75
22.38
%
0.92
822
7925
18
62
2.90
4.14
1.1
1.2
—
—
—
0
0
36
173
2.08
4.12
1.2
1.1
—
—
—
0
0
36
173
2.08
4.12
1.1
1.1
—
—
—
0
0
1022
11462
0.87
4.11
1.5
1.6
1.19
1.27
mmol/l
3.85
846
9320
7
252
0.28
4.11
1.0
1.1
—
—
—
0
0
21
497
0.42
4.09
1.9
2.1
529.56
635.25
ml
—
9
302
164
2238
0.72
4.06
2.1
2.9
271.69
3224.51
u/ml
1.54
126
1873
177
2385
0.73
4.05
2.3
2.9
1.39
2.95
ratio
—
8
176
58
979
0.59
4.04
1.3
1.2
7.10
5.26
u/ml
—
9
151
124
1757
0.70
3.86
1.5
1.6
37.07
38.13
u/l
0.26
97
1454
58
966
0.60
3.86
1.3
1.2
3.20
8.03
u/ml
—
8
96
18
437
0.41
3.76
1.2
1.4
—
—
—
0
0
148
1063
1.40
3.73
1.5
2.1
26.14
32.31
umol/l
2.26
116
913
18
66
2.72
3.72
1.1
1.2
—
—
—
0
0
26
543
0.48
3.68
1.6
3.5
23.43
45.41
u/ml
1.65
26
525
69
424
1.63
3.67
2.6
2.4
—
—
—
0
0
35
658
0.53
3.61
3.3
3.6
49.52
58.61
%
1.00
23
527
32
156
2.05
3.57
2.3
2.0
58.19
50.44
umol/l
0.76
26
119
44
766
0.57
3.50
1.3
1.4
—
—
—
0
0
11
322
0.34
3.49
3.5
3.4
—
—
—
0
0
2207
20592
1.10
3.46
2.6
2.9
125.74
156.70
ug/l
7.81
1935
18229
66
1035
0.63
3.45
1.3
1.2
34.13
45.61
u/ml
—
7
57
32
608
0.52
3.44
1.7
2.0
6.54
913.65
u/ml
1.20
32
597
557
4775
1.18
3.31
1.9
2.4
31.88
36.58
u/l
1.92
459
4042
24
494
0.48
3.30
1.2
1.2
—
—
—
0
0
14
353
0.39
3.24
1.4
1.2
—
—
—
0
0
72
1091
0.65
3.24
1.6
1.7
13.18
12.83
mg/l
0.09
64
982
102
1441
0.70
3.19
1.2
1.2
0.64
1.14
u/ml
—
10
146
131
1774
0.73
3.17
2.0
1.6
—
—
—
0
0
7
219
0.32
3.17
1.1
1.5
—
—
—
0
0
7
219
0.32
3.17
1.1
1.5
—
—
—
0
0
41
705
0.58
3.15
3.3
3.5
—
—
—
0
0
911
8132
1.14
3.12
1.2
1.2
1.02
1.61
u/ml
2.37
185
1921
16
61
2.62
3.11
1.0
1.2
4.60
52.45
%
—
5
22
15
56
2.67
3.03
1.1
1.1
—
—
—
0
0
4009
41324
0.92
3.02
3.7
4.2
1.17
1.24
mmol/l
11.71
3435
35575
32
167
1.92
3.01
1.6
1.4
81.58
87.56
umol/l
0.11
19
101
85
1226
0.69
3.00
2.0
2.4
1.68
1.87
mg/l
1.37
76
1046
10
279
0.36
2.93
1.3
1.5
—
—
—
0
0
8
223
0.36
2.90
1.3
1.5
—
—
—
0
0
1209
13141
0.90
2.86
2.1
2.5
—
—
—
0
0
322
3846
0.83
2.84
1.3
1.3
—
—
—
0
0
17
372
0.45
2.82
1.2
1.5
—
—
—
0
0
17
372
0.45
2.82
1.2
1.5
—
—
—
0
0
87
1233
0.70
2.81
1.9
2.1
3.51
3.63
g/l
0.37
79
1154
82
1174
0.69
2.81
1.4
1.5
0.46
10.88
iu/ml
1.21
27
314
179
1390
1.29
2.78
3.8
5.8
105.23
104.72
mmol/l
0.80
157
1240
513
5869
0.86
2.73
1.9
2.4
65.85
65.66
g/l
0.23
420
5112
2100
22183
0.92
2.71
2.7
3.4
1804.65
2166.81
ng/l
2.84
1785
19259
194
2430
0.79
2.70
2.6
4.2
25.08
24.89
mmol/l
0.38
161
2153
11
279
0.39
2.64
1.3
1.5
—
—
—
0
0
0
67
0.00
2.60
0.0
1.2
—
6.39
—
0
50
673
5969
1.14
2.57
4.0
6.3
119.60
118.59
g/l
0.69
646
5795
18
370
0.48
2.54
2.8
3.5
—
—
—
0
0
30
163
1.84
2.54
1.1
1.0
—
—
—
0
0
36
600
0.60
2.53
1.0
1.2
—
18.38
—
0
10
13
50
2.60
2.51
1.0
1.1
—
—
—
0
0
4169
42744
0.92
2.45
4.2
4.7
1.48
1.45
mmol/l
4.96
3641
37301
21
102
2.06
2.45
1.1
1.1
—
—
—
0
0
69
983
0.70
2.36
1.2
1.2
47.09
43.60
u/l
0.08
55
834
817
8978
0.89
2.35
2.1
2.5
21.23
20.41
%
0.93
596
7438
17
78
2.18
2.29
11.8
8.9
13.74
13.96
%
0.41
17
78
88
1196
0.73
2.28
1.8
1.6
—
—
—
0
0
6
168
0.36
2.27
2.5
1.2
—
—
—
0
0
5
156
0.32
2.26
1.2
1.2
141.40
147.07
mmol/24h
—
5
156
593
5265
1.14
2.26
2.8
3.8
1.23
1.23
mmol/l
1.23
462
4495
0
59
0.00
2.24
0.0
1.1
—
—
—
0
0
22
402
0.54
2.20
1.0
1.1
—
1.97
—
0
16
193
1563
1.24
2.19
1.4
1.4
248.62
263.94
ug/g
0.51
104
980
85
1150
0.73
2.16
1.4
1.4
0.23
0.23
g/l
0.16
76
1070
866
9428
0.90
2.10
2.0
2.5
2.21
2.25
g/l
1.06
762
8528
49
322
1.52
2.10
1.2
1.2
—
786.67
—
0
6
11
43
2.55
2.07
1.1
1.0
—
—
—
0
0
0
57
0.00
2.05
0.0
1.4
—
—
—
0
0
89
1179
0.75
1.99
1.5
1.4
1.13
1.15
g/l
0.37
81
1097
42
634
0.66
1.99
1.3
1.3
0.40
0.27
nmol/l
—
7
50
37
231
1.60
1.99
1.2
1.2
0.65
0.98
promille
0.96
26
171
132
1659
0.79
1.98
1.5
1.6
—
—
—
0
0
254
2985
0.84
1.96
1.6
1.8
1.70
2.68
ug/l
1.36
197
2498
46
679
0.67
1.96
1.3
1.2
61.76
41.54
u/ml
—
5
79
4619
45074
1.07
1.92
5.0
5.3
6.11
6.14
mmol/l
1.14
3997
39113
304
3511
0.86
1.91
1.3
1.6
1.55
1.55
g/l
0.02
243
2951
2700
25886
1.07
1.89
2.7
3.1
43.79
58.03
u/l
17.35
2369
22906
478
4246
1.13
1.85
1.7
1.8
140.37
179.23
ug/g
2.07
357
3220
11
46
2.39
1.84
1.1
1.0
—
—
—
0
0
74
993
0.74
1.83
2.8
3.3
59.07
60.06
%
0.26
74
993
75
1004
0.74
1.83
1.3
1.5
—
—
—
0
0
741
6761
1.10
1.79
2.9
3.2
189.63
283.12
ng/l
12.07
675
6201
287
3309
0.86
1.78
4.3
7.0
24.48
24.39
mmol/l
0.15
268
3114
47
675
0.69
1.76
1.4
1.5
—
—
—
0
0
38
247
1.54
1.76
1.2
1.1
—
—
—
0
0
35
532
0.65
1.75
1.1
1.3
222.26
257.48
pmol/l
0.69
27
444
343
2999
1.15
1.70
2.1
3.4
24.58
24.11
mmol/l
2.09
326
2896
71
946
0.75
1.70
1.5
1.4
—
—
—
0
0
64
865
0.74
1.69
1.4
1.4
—
—
—
0
0
30
466
0.64
1.67
1.2
1.1
—
—
—
0
0
37
549
0.67
1.66
1.0
1.2
62.33
62.96
u/l
0.03
30
484
88
1133
0.77
1.65
1.8
1.9
97.83
87.30
%
4.74
81
1085
34
512
0.66
1.64
1.0
1.3
112.00
119.19
u/ml
—
9
111
239
2775
0.85
1.64
2.0
2.3
3.75
3.68
g/l
0.29
196
2394
5
131
0.38
1.62
1.0
1.4
—
—
—
0
0
57
778
0.73
1.61
1.4
1.4
—
—
—
0
0
728
6675
1.10
1.61
3.8
5.8
95.87
95.14
%
2.58
689
6385
23
135
1.70
1.60
1.2
1.1
1.05
1.21
u/l
1.30
13
74
102
801
1.27
1.59
1.6
1.6
—
—
—
0
0
813
7504
1.09
1.56
3.7
5.6
4.93
5.05
kpa
2.96
757
7060
241
2783
0.86
1.56
2.0
2.3
—
—
—
0
0
251
2162
1.16
1.55
1.2
1.3
66.71
59.63
au/ml
—
9
120
17
92
1.84
1.54
1.1
1.1
—
—
—
0
0
812
7501
1.09
1.53
3.7
5.6
11.63
11.62
kpa
0.03
757
7048
3124
30228
1.06
1.53
20.0
21.9
1.34
1.43
inr
4.12
754
8200
242
2788
0.86
1.53
2.0
2.3
7.45
7.61
g/l
0.69
196
2402
60
804
0.74
1.52
1.2
1.3
0.57
0.82
nmol/l
5.02
51
643
94
737
1.28
1.50
1.1
1.1
—
—
—
0
0
20
332
0.60
1.50
1.5
1.5
4.73
7.38
u/l
0.59
15
257
66
868
0.76
1.48
1.6
2.0
32.61
32.43
pg
0.14
66
858
811
7511
1.09
1.45
3.7
5.6
1.22
1.23
mmol/l
0.03
621
5795
4258
43295
0.94
1.44
4.3
4.7
4.34
4.35
mmol/l
0.24
3752
38154
254
2900
0.87
1.43
1.8
2.0
—
—
—
0
0
9
39
2.30
1.42
1.0
1.1
—
—
—
0
0
611
5595
1.10
1.41
3.2
5.2
1.45
1.42
mmol/l
0.29
597
5388
234
2684
0.86
1.41
1.8
1.8
—
—
—
0
0
84
1060
0.79
1.39
2.5
2.1
212.25
213.39
%
0.04
73
996
12
224
0.53
1.39
1.3
1.3
1.67
1.68
u/ml
—
7
136
4457
43632
1.06
1.37
6.3
6.9
41.34
41.54
mmol/mol
0.64
3967
38747
4222
42904
0.95
1.34
17.1
18.9
69.95
67.02
ml/min/173m2
18.67
3453
35639
40
556
0.72
1.32
1.3
1.5
—
—
—
0
0
2443
25171
0.95
1.30
4.5
5.3
0.19
0.20
e9/l
0.56
2056
21368
15
83
1.80
1.30
1.3
1.1
1576.13
1735.39
miu/ml
0.17
15
83
9
43
2.09
1.29
1.1
1.1
—
—
—
0
0
68
867
0.78
1.25
1.2
1.2
—
—
—
0
0
49
653
0.75
1.25
2.6
3.0
—
—
—
0
0
5
115
0.43
1.24
1.2
1.4
99.60
253.74
nmol/24h
—
5
115
48
640
0.75
1.23
1.2
1.1
—
—
—
0
0
1338
13994
0.94
1.21
2.4
3.0
35.21
36.73
u/l
0.26
1218
13027
7
145
0.48
1.19
1.0
1.2
—
—
—
0
0
665
7120
0.92
1.18
1.3
1.5
2.51
2.79
g/l
2.56
283
3810
265
2347
1.13
1.17
2.4
2.9
4.26
4.27
pmol/l
0.12
223
1960
20
309
0.64
1.16
2.3
1.8
88.10
98.66
umol/l
0.97
20
309
16
94
1.70
1.16
1.1
1.3
80.39
100.88
ug/l
0.29
11
60
67
524
1.28
1.16
1.3
1.4
—
—
—
0
0
68
533
1.27
1.15
1.3
1.3
—
—
—
0
0
20
308
0.65
1.15
1.1
1.2
18.40
30.45
u/l
0.79
15
252
0
36
0.00
1.13
0.0
1.3
—
0.65
—
0
18
8
153
0.52
1.13
1.0
1.1
—
—
—
0
0
36
494
0.73
1.13
1.0
1.1
—
—
—
0
0
18
282
0.64
1.12
1.1
1.0
—
—
—
0
0
39
526
0.74
1.11
1.1
1.1
—
—
—
0
0
51
388
1.31
1.09
1.2
1.2
1.12
1.44
nmol/l
2.00
46
342
2368
24315
0.95
1.06
4.4
5.2
0.60
0.64
e9/l
11.48
1952
20424
332
3646
0.90
1.06
2.4
3.4
25.35
25.21
mmol/l
0.37
320
3540
16
97
1.65
1.05
2.1
2.2
—
—
—
0
0
235
2629
0.89
1.04
2.0
2.2
10.02
10.31
g/l
0.50
190
2214
23
335
0.68
1.03
1.0
1.4
—
—
—
0
0
23
335
0.68
1.03
1.0
1.4
—
—
—
0
0
2427
24894
0.96
1.03
4.6
5.3
1.70
1.85
e9/l
5.27
2045
21345
72
886
0.81
1.03
2.2
2.1
27.27
27.37
mg/l
0.00
22
206
115
1352
0.85
1.02
1.4
1.4
—
—
—
0
0
40
529
0.75
1.02
1.6
1.4
18.24
26.00
%
1.33
27
335
20
131
1.52
0.98
1.1
1.1
—
—
—
0
0
24
342
0.70
0.97
3.7
3.6
73.33
196.57
nmol/l
4.64
24
336
0
30
0.00
0.97
0.0
4.6
—
—
—
0
0
18
271
0.66
0.97
3.1
1.8
—
—
—
0
0
0
31
0.00
0.96
0.0
1.0
—
—
—
0
0
128
1096
1.17
0.96
1.5
1.6
—
—
—
0
0
315
3447
0.91
0.96
3.4
5.7
24.75
24.95
mmol/l
0.44
309
3402
17
258
0.66
0.95
1.1
2.6
61.00
67.06
mg/l
0.17
12
171
110
1287
0.85
0.94
1.4
1.4
—
—
—
0
0
893
9376
0.94
0.94
2.0
2.7
0.82
0.81
mmol/l
1.06
805
8496
46
588
0.78
0.93
1.2
1.2
—
—
—
0
0
65
524
1.24
0.92
1.5
1.3
—
—
—
0
0
104
879
1.18
0.92
1.5
1.6
3.94
4.28
iu/l
0.12
27
241
60
738
0.81
0.89
1.2
1.4
—
—
—
0
0
884
8380
1.06
0.88
1.8
2.2
1.67
1.78
%
2.98
733
7173
56
693
0.80
0.88
1.5
1.5
62.97
63.95
%
0.07
38
441
36
468
0.77
0.85
1.2
1.4
—
—
—
0
0
36
468
0.77
0.85
1.2
1.4
—
—
—
0
0
36
468
0.77
0.85
1.2
1.4
—
—
—
0
0
6
111
0.54
0.83
1.2
1.3
114.82
142.48
pmol/l
—
6
111
15
225
0.66
0.82
1.5
1.1
0.31
0.93
u/ml
—
9
115
123
1406
0.87
0.81
4.4
3.9
31.99
30.90
mg/l
0.11
85
950
64
524
1.22
0.81
1.5
1.3
—
—
—
0
0
170
1902
0.89
0.81
1.1
1.1
68.19
117.38
iu/ml
1.72
56
609
1366
13134
1.05
0.80
3.3
3.9
80.33
81.46
%
0.87
1327
12798
38
486
0.78
0.80
1.1
1.1
293.24
311.46
u/ml
0.12
21
276
15
97
1.54
0.80
2.2
2.2
—
—
—
0
0
19
270
0.70
0.79
2.9
1.8
17.05
18.14
%
0.17
19
259
249
2260
1.10
0.79
1.8
2.1
1718.36
541.30
ug/l
0.77
233
2132
334
3605
0.92
0.79
1.3
1.2
—
—
—
0
0
576
5416
1.07
0.77
2.2
3.0
4.26
4.33
kpa
0.31
551
5204
186
1665
1.12
0.77
1.1
1.1
—
—
—
0
0
62
746
0.83
0.77
1.2
1.4
—
—
—
0
0
13
82
1.58
0.77
3.3
3.0
0.31
0.52
u/field
0.70
13
82
62
744
0.83
0.75
1.2
1.4
—
—
—
0
0
62
743
0.83
0.74
1.2
1.4
—
—
—
0
0
233
2543
0.91
0.72
2.1
2.3
3.07
3.05
g/l
0.09
189
2155
5
25
1.99
0.72
1.0
1.0
—
—
—
0
0
137
1538
0.89
0.72
1.2
1.4
—
—
—
0
0
5
26
1.92
0.70
1.2
1.2
—
—
—
0
0
63
746
0.84
0.68
1.2
1.4
—
—
—
0
0
7
119
0.59
0.67
2.0
1.8
28.86
29.46
%
—
7
108
1046
10826
0.96
0.67
1.5
1.7
1.78
1.62
mg/l
0.50
788
8483
5
91
0.55
0.67
1.2
1.3
1.85
1.54
g/l
—
5
91
70
816
0.85
0.64
1.3
1.4
—
—
—
0
0
5
29
1.72
0.63
1.0
1.0
—
—
—
0
0
66
772
0.85
0.63
1.2
1.2
—
—
—
0
0
60
505
1.19
0.62
1.1
1.4
—
—
—
0
0
5
30
1.66
0.61
1.2
1.1
—
—
—
0
0
13
186
0.70
0.60
1.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
129
1431
0.90
0.59
1.8
2.1
102.32
95.60
ug/min
0.07
49
805
65
755
0.86
0.59
1.2
1.4
—
—
—
0
0
0
23
0.00
0.58
0.0
3.7
—
—
—
0
0
105
1176
0.89
0.57
1.5
1.5
—
—
—
0
0
4464
44941
0.97
0.56
5.0
5.4
2.43
2.47
mmol/l
2.02
3944
39434
5
89
0.56
0.55
1.0
1.2
—
—
—
0
0
54
633
0.85
0.55
1.8
1.7
31.77
25.72
u/ml
0.34
13
142
536
5093
1.05
0.55
2.5
3.4
79.54
97.92
ng/l
7.27
435
4135
443
4188
1.06
0.55
1.6
2.0
402.48
386.73
nmol/l
0.98
383
3712
75
653
1.15
0.53
1.4
1.5
3.07
2.95
mg/l
0.04
60
505
20
260
0.77
0.53
1.9
2.2
—
—
—
0
0
2816
28521
0.97
0.53
5.7
8.0
4.43
4.48
e9/l
0.43
2373
24428
6
39
1.53
0.53
2.7
1.4
—
—
—
0
0
30
240
1.25
0.52
1.4
1.2
1.10
1.07
nmol/l
0.07
23
179
40
477
0.84
0.51
1.2
1.1
63.71
547.90
iu/ml
—
7
78
987
10155
0.96
0.50
2.0
2.5
11.77
11.37
umol/l
1.01
867
9205
27
332
0.81
0.47
1.1
1.1
4.70
3.12
u/ml
—
5
70
212
2267
0.93
0.47
3.6
3.2
0.78
0.81
nmol/l
0.85
171
1745
219
2333
0.93
0.45
2.1
2.0
11.65
10.73
nmol/l
0.85
191
1947
142
1538
0.92
0.44
2.0
2.3
126.43
125.05
g/l
0.35
120
1130
40
338
1.18
0.44
1.6
1.7
167.65
197.03
pmol/l
1.18
34
306
49
564
0.87
0.43
1.2
1.3
309372.37
182908.47
e6/l
0.37
30
381
9
129
0.70
0.43
6.1
3.2
—
68.64
u/ml
—
0
14
20
251
0.79
0.43
1.1
1.1
—
—
—
0
0
20
250
0.80
0.42
1.1
1.1
—
—
—
0
0
20
250
0.80
0.42
1.1
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
17
131
1.29
0.41
1.0
1.1
—
—
—
0
0
20
249
0.80
0.40
1.1
1.1
—
—
—
0
0
20
248
0.80
0.39
1.1
1.1
—
—
—
0
0
24
291
0.82
0.39
1.6
1.9
—
—
—
0
0
2066
20931
0.98
0.39
8.7
10.7
0.00
0.00
e9/l
2.01
1646
16893
1030
10014
1.03
0.39
3.1
3.4
0.73
0.87
ug/l
6.20
756
7405
33
278
1.18
0.38
1.1
1.3
—
—
—
0
0
16
124
1.29
0.38
1.1
1.1
—
—
—
0
0
36
418
0.86
0.37
1.4
1.3
7.74
12.62
u/l
2.56
29
324
188
1992
0.94
0.36
2.2
2.3
0.03
0.05
g/l
0.54
163
1765
10
134
0.74
0.35
1.6
1.2
—
—
—
0
0
54
479
1.13
0.34
1.1
1.4
—
—
—
0
0
11
144
0.76
0.33
3.7
1.7
—
—
—
0
0
391
4050
0.96
0.32
2.5
2.9
57.81
56.00
ml/min/173m2
0.55
170
1920
20
164
1.22
0.32
1.1
1.3
—
—
—
0
0
37
421
0.88
0.31
1.1
1.1
1.89
3.51
u/ml
—
9
130
137
1457
0.94
0.31
2.1
2.5
16.28
15.59
%
1.65
64
745
26
303
0.86
0.30
1.4
1.3
—
—
—
0
0
12
93
1.29
0.29
1.1
1.2
—
—
—
0
0
74
803
0.92
0.28
1.7
1.7
3.81
4.31
mmol/24h
0.84
60
661
667
6488
1.03
0.27
2.3
3.4
5.84
5.83
kpa
0.14
640
6261
9
117
0.77
0.27
1.0
1.1
—
—
—
0
0
597
5801
1.03
0.26
1.9
2.5
10.30
9.98
umol/l
0.11
497
4984
5
75
0.66
0.25
1.6
1.5
38.40
47.65
umol/l
—
5
75
9
73
1.23
0.25
1.0
1.2
—
—
—
0
0
15
123
1.22
0.24
1.3
1.4
0.18
0.13
nmol/l
—
9
93
18
152
1.18
0.23
1.3
1.4
15.83
16.51
pmol/l
0.27
13
110
17
143
1.19
0.22
1.2
1.3
29.83
29.54
%
0.01
12
94
75
802
0.93
0.22
1.5
1.4
—
—
—
0
0
75
802
0.93
0.22
1.5
1.4
—
—
—
0
0
22
190
1.16
0.22
1.1
1.3
66.83
65.17
%
0.08
15
161
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
7.5
—
55.36
—
0
11
8
102
0.78
0.21
1.9
1.9
—
—
—
0
0
6
49
1.22
0.20
1.0
1.1
1.80
1.72
umol/24h
—
6
49
181
1874
0.96
0.19
2.3
2.3
0.00
0.00
g/l
1.25
156
1656
6
53
1.13
0.18
1.0
1.2
14.00
17.67
pmol/l
—
6
46
2872
28449
1.01
0.18
3.6
5.7
12.50
12.55
umol/l
0.07
2626
26760
19
166
1.14
0.17
1.5
1.6
11.47
7.46
nmol/l
0.19
19
140
5
66
0.76
0.17
1.0
1.3
—
—
—
0
0
178
1836
0.97
0.16
2.3
2.3
0.00
0.00
g/l
-0.00
155
1648
8
70
1.14
0.16
1.0
1.1
—
—
—
0
0
38
349
1.09
0.16
1.2
1.2
—
—
—
0
0
659
6470
1.02
0.15
2.3
3.4
2.18
2.01
mmol/l
0.59
554
5411
30
273
1.10
0.15
1.0
1.1
90.35
91.39
%
0.11
23
249
77
729
1.05
0.15
1.4
1.4
—
—
—
0
0
34
368
0.92
0.15
1.1
1.1
—
—
—
0
0
74
700
1.05
0.15
1.6
1.4
—
—
—
0
0
7
88
0.79
0.14
1.4
1.5
10.32
9.86
ug/l
—
7
88
89
848
1.05
0.14
5.4
10.5
7.31
7.44
mmol/l
0.14
69
686
330
3222
1.02
0.14
2.0
2.4
0.68
0.66
%
0.66
330
3207
147
1514
0.97
0.13
2.7
4.5
4.97
5.03
kpa
0.41
139
1468
147
1512
0.97
0.13
2.7
4.5
2.02
2.87
mmol/l
4.69
100
1040
36
335
1.07
0.12
2.6
2.0
2.57
2.56
u/field
0.00
23
220
19
171
1.11
0.12
1.2
1.1
—
—
—
0
0
50
525
0.95
0.11
1.3
1.3
268.33
297.12
titre
—
6
66
5
44
1.13
0.10
3.2
1.6
—
—
—
0
0
5
44
1.13
0.10
1.0
1.1
—
—
—
0
0
21
194
1.08
0.08
1.2
1.1
—
—
—
0
0
7
64
1.09
0.08
1.9
2.6
107.29
155.40
nmol/l
—
7
52
228
2311
0.98
0.08
2.1
2.4
1.05
1.07
g/l
0.03
176
1884
51
488
1.04
0.08
1.6
1.5
56.49
50.16
nmol/l
0.67
51
458
23
245
0.94
0.07
1.0
1.0
—
—
—
0
0
127
1239
1.02
0.07
1.3
1.3
—
—
—
0
0
50
518
0.96
0.07
1.6
1.3
—
—
—
0
0
293
2887
1.01
0.06
3.6
4.3
1.57
1.54
%
0.38
269
2717
14
128
1.09
0.06
1.1
1.1
—
—
—
0
0
15
138
1.08
0.06
1.3
1.5
15.85
295.12
ug/l
0.76
15
127
948
9401
1.01
0.06
1.7
1.9
29.19
30.25
s
6.52
921
9065
629
6315
0.99
0.06
1.9
2.4
64.07
67.38
e9/l
1.58
485
4818
11
120
0.91
0.05
1.6
1.5
142.20
133.69
ng/l
0.08
11
120
420
4221
0.99
0.05
2.2
3.2
127.00
125.31
g/l
0.98
412
4113
136
1377
0.98
0.05
1.4
1.6
27480.43
16084.81
e6/l
0.69
94
988
35
362
0.96
0.04
1.1
1.4
—
—
—
0
0
35
362
0.96
0.04
1.1
1.4
—
—
—
0
0
332
3283
1.01
0.04
2.0
2.4
1.09
1.11
%
0.30
332
3266
530
5252
1.01
0.04
1.6
1.9
0.20
0.19
g/l
2.77
471
4768
22
230
0.95
0.04
1.0
1.2
—
—
—
0
0
76
771
0.98
0.03
4.4
5.9
12.98
12.76
mg/l
0.12
65
686
22
229
0.96
0.03
1.0
1.2
—
—
—
0
0
643
6385
1.00
0.03
4.1
4.1
—
—
—
0
0
14
131
1.07
0.03
1.6
1.3
—
—
—
0
0
36
369
0.97
0.03
1.1
1.1
—
—
—
0
0
218
2158
1.01
0.02
2.1
2.2
37.40
36.67
g/l
1.08
172
1762
59
599
0.98
0.02
1.4
1.3
276.17
274.43
mosm/kgh2o
0.22
41
421
58
571
1.01
0.01
1.5
1.3
—
—
—
0
0
12
114
1.05
0.00
1.1
1.1
—
—
—
0
0
287
2856
1.00
0.00
3.4
4.3
0.92
0.86
%
1.83
265
2686
12
120
1.00
0.00
1.5
1.1
0.71
0.64
umol/24h
—
6
48
20
204
0.98
0.00
1.3
1.2
4.68
12.44
umol/l
1.67
12
133
40
401
0.99
0.00
1.1
1.1
2.93
4.29
u/ml
0.85
14
188
17
170
1.00
0.00
1.1
1.2
—
—
—
0
0
134
1338
1.00
0.00
1.3
1.3
66.74
59.81
mmol/l
1.25
110
1058
21
212
0.99
0.00
2.0
2.1
—
—
—
0
0
21
212
0.99
0.00
2.0
2.1
—
—
—
0
0
35
352
0.99
0.00
1.0
1.1
114.04
114.77
%
0.05
27
302
60
603
0.99
0.00
1.5
1.5
—
—
—
0
0
38
375
1.01
0.00
1.6
1.7
—
—
—
0
0
21
208
1.01
0.00
7.3
5.0
70.62
70.91
%
0.02
16
160
17
167
1.02
0.00
1.5
1.4
—
—
—
0
0
66
656
1.00
0.00
2.5
2.4
2.64
2.21
u/field
0.17
25
196
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
6.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
79
1.01
-0.00
1.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.1
—
—
—
0
0
9
92
0.98
-0.00
1.1
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
2.63
—
0
7
0
9
0.00
-0.00
0.0
1.1
—
8.63
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
5.1
—
366.29
—
0
7
0
7
0.00
-0.00
0.0
2.3
—
—
—
0
0
5
52
0.96
-0.00
1.4
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ADMED_ACHEI_RIVASTIGMINE – Use of rivastigmine
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).